Specific

B melanoma antigen 1; B melanoma antigen; antigen MZ2-BA; cancer/testis antigen 2.1; CT2.1 (BAGE, BAGE1) B melanoma antigen 2 (BAGE2) B melanoma antigen 3 (BAGE3) B melanoma antigen 4 (BAGE4 MLL3P) B melanoma antigen 5 (BAGE5) CD228, melanotransferrin or melanoma-associated antigen p97 CD63; granulophysin; tetraspanin-30; Tspan-30; melanoma-associated antigen ME491; platelet activation antigen Pltgp40; ocular melanoma-associated antigen OMA81H; lysosome-associated membrane glycoprotein-3; lamp-3; antigen AD1 (NKI/C3) cell surface glycoprotein MUC18; melanoma-associated antigen MUC18; melanoma cell adhesion molecule; melanoma-associated antigen A32; S-endo 1 endothelial-associated antigen; cell surface glycoprotein P1H12; CD146 (MCAM, MUC18) melanoma antigen recognized by T-cells 1; MART-1; melan-A protein; antigen SK29-AA; antigen LB39-AA (MLANA, MART1) melanoma associated antigen-C2 ( MAGE-C2, hepatocellular cancer antigen 587, cancer-testis antigen CT10) melanoma-associated antigen 10; MAGE-10 antigen; cancer/testis antigen 1.10; CT1.10 (MAGEA10, MAGE10) melanoma-associated antigen 11; MAGE-11 antigen; cancer/testis antigen 1.11; CT1.11 (MAGEA11, MAGE11) melanoma-associated antigen 12; MAGE-12 antigen; MAGE12F antigen; cancer/testis antigen 1.12; CT1.12 (MAGEA12 MAGE12) melanoma-associated antigen 1; MAGE-1 antigen; antigen MZ2-E; cancer/testis antigen 1.1; CT1.1 (MAGEA1, MAGE1, MAGE1A) melanoma-associated antigen 2; MAGE-2 antigen; cancer/testis antigen 1.2; CT1.2 (MAGEA2, MAGE2, MAGEA2A, MAGEA2B, MAGE2, MAGEA2) melanoma-associated antigen 3; MAGE-3 antigen; antigen MZ2-D; cancer/testis antigen 1.3; CT1.3 (MAGEA3, MAGE3) melanoma-associated antigen 4; MAGE-4 antigen; MAGE-X2 antigen; MAGE-41 antigen; cancer/testis antigen 1.4; CT1.4 (MAGEA4, MAGE4) melanoma-associated antigen 5; MAGE-5 antigen; cancer/testis antigen 1.5; CT1.5 (MAGEA5, MAGE5) melanoma-associated antigen 6; MAGE-6 antigen; MAGE3B antigen; cancer/testis antigen 1.6; CT1.6 (MAGEA6, MAGE6) melanoma-associated antigen 8; MAGE-8 antigen; cancer/testis antigen 1.8; CT1.8 (MAGEA8, MAGE8) melanoma-associated antigen 9; MAGE-9 antigen; cancer/testis antigen 1.9; CT1.9 (MAGEA9, MAGE9, MAGEA9A, MAGEA9B) melanoma-associated antigen B10 (MAGE-B10 antigen, MAGEB10) melanoma-associated antigen B16 (MAGE-B16 antigen, MAGEB16) Melanoma-associated antigen B18 (MAGE-B18 antigen, MAGEB18) melanoma-associated antigen B1; MAGE-B1 antigen; MAGE-XP antigen; DSS-AHC critical interval MAGE superfamily 10; DAM10; cancer/testis antigen 3.1; CT3.1 (MAGEB1, MAGEL1, MAGEXP) melanoma-associated antigen B2; MAGE-B2 antigen; DSS-AHC critical interval MAGE superfamily 6; DAM6; MAGE XP-2 antigen; cancer/testis antigen 3.2; CT3.2 (MAGEB2) melanoma-associated antigen B3; MAGE-B3 antigen (MAGEB3) melanoma-associated antigen B4; MAGE-B4 antigen (MAGEB4) melanoma-associated antigen B5; MAGE-B5 antigen; cancer/testis antigen 3.3; CT3.3 (MAGEB5) melanoma-associated antigen B6B (MAGEB6B) melanoma-associated antigen C1; MAGE-C1 antigen; cancer/testis antigen 7.1; CT7.1 (MAGEC1) melanoma-associated antigen C3 (MAGE-C3 antigen, hepatocellular carcinoma-associated antigen 2, MAGEC3, HCA2) melanoma-associated antigen D1; MAGE-D1 antigen; neurotrophin receptor-interacting MAGE homolog; MAGE tumor antigen CCF (MAGED1, NRAGE, PRO2292, PP2250) melanoma-associated antigen D2; MAGE-D2 antigen; MAGE-D; breast cancer-associated gene 1 protein; BCG-1; 11B6; hepatocellular carcinoma-associated protein JCL-1 (MAGED2, BCG1) melanoma-associated antigen D4 (MAGE-D4 antigen, MAGE-E1 antigen, MAGED4, KIAA1859, MAGEE1) melanoma-associated antigen E1; MAGE-E1 antigen; hepatocellular carcinoma-associated protein 1 (MAGEE1, HCA1, KIAA1587) melanoma-associated antigen E2 (MAGE-E2 antigen, hepatocellular carcinoma-associated protein 3, MAGEE2, HCA3) melanoma-associated antigen F1 (MAGE-F1 antigen, MAGEF1) melanoma-associated antigen G1 (MAGE-G1 antigen, necdin-like protein 2, hepatocellular carcinoma-associated protein 4, NDNL2, HCA4, MAGEG1) melanoma-associated antigen H1; MAGE-H1 antigen; restin; apoptosis-related protein 1; APR-1 (MAGEH1, APR1) peroxidasin homolog (vascular peroxidase, melanoma-associated antigen MG50, p53-responsive gene 2 protein) (PXDN KIAA0230 MG50 PRG2 VPO) zinc finger protein 654 (melanoma-associated antigen, ZNF654)

General

antigen other protein